Company: MIRM
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001759425-25-000022
Chunk: 73

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 73
---
, consists of the following held directly: 42,167 shares of common stock subject to options that are exercisable within 60 days of the Measurement Date.

(17) For Dr. Quan, consists of the following held directly: (i) 5,649 shares of common stock, (ii) 23,437 shares of common stock subject to options that are exercisable within 60 days of the Measurement Date and (iii) 12,500 shares underlying restricted stock units that will vest and settle within 60 days of the Measurement Period.

(18) For Mr. Walbert, consists of the following held directly: 24,084 shares of common stock subject to options that are exercisable within 60 days of the Measurement Date.

(19) Includes 7,472,934 shares of common stock that our executive officers and non-employee directors hold directly and have the right to acquire pursuant to options exercisable within 60 days of the Measurement Date.

#### 58Mirum Pharmaceuticals2025 Proxy Statement

### TABLE OF CONTENTS
| Securities Authorized for Issuance under Equity Compensation Plan |

#### Equity Compensation Plan Information
The following table provides certain information as of December 31, 2024, with respect to all of our equity compensation plans in effect on that date.

| Plan Category                                                 |     | Number of        
 Securities to be 
 Issued upon      
 Exercise of      
 Outstanding      
 Options,         
 Warrants         
 and Rights       |            |     |    |     |    | Weighted-   
 average     
 Exercise    
 Price of    
 Outstanding 
 Options,    
 Warrants    
 and Rights  |        |    | Number of       
 Securities      
 Remaining       
 Available for   
 Future Issuance 
 under Equity    
 Compensation    
 Plans           
 (Excluding      
 Securities      
 Reflected in    
 Column (a))     |           |     |    |     |    |
|                                                               |     |                  |            |     |    |     | -a |             |        | -b |                 |           |     |    |     | -c |
| Equity compensation plans approved by security holders(1)     |     |                  |  8,984,273 |     | -2 |     |    |             | $16.27 |    |                 | 3,181,734 |     | -3 |     |    |
| Equity compensation plans not approved by security holders(4) |     |                  |  2,724,730 |     |    |     |